CSJ148

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSJ148, covering 2018-02-26 to 2018-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients [Phase 2]